View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule ...

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on May 1, 2024, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 15,000 shares of Class A common stock and restricted stock units (RSUs) for 7,500 shares of Class A common stock to three new employees under Vera’s 2024 Inducement Plan (the Inducement Plan). Vera also announced that on May 6, 2024, the Compensation ...

 PRESS RELEASE

NewtekOne, Inc. Reports First Quarter 2024 Financial Results

NewtekOne, Inc. Reports First Quarter 2024 Financial Results Achieves Growth in Loans and Deposits in the First Quarter 2024 First Quarter 2024 Earnings per Share Beats Company’s Previously Issued Forecast; Company Raises Full Year 2024 Earnings per Share Forecast BOCA RATON, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (Nasdaq: NEWT), announced today its financial and operating results for the three months ended March 31, 2024. NewtekOne First Quarter 2024 Financial Highlights Net income was $9.7 million, or $0.38 per ...

 PRESS RELEASE

Chart Industries Reports First Quarter 2024 Financial Results

Chart Industries Reports First Quarter 2024 Financial Results ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”) today reported results for the first quarter ended March 31, 2024. Results shown are from continuing operations. When referring to any comparative period, all metrics are pro forma for continuing operations of the combined business of Chart and Howden, unless noted otherwise. First quarter 2024 highlights compared to first quarter 2023, pro forma: Orders, backlog, sales, reported and adjusted gross margin, reported and adjusted op...

 PRESS RELEASE

New Mountain Finance Corporation Announces Financial Results for the Q...

NEW YORK--(BUSINESS WIRE)-- New Mountain Finance Corporation (NASDAQ: NMFC) (“New Mountain,” “New Mountain Finance” or the “Company”) today announced its financial results for the quarter ended March 31, 2024. First Quarter Highlights1 Net investment income of $37.3 million, or $0.36 per weighted average share Net asset value of $12.77 per share compared to $12.87 per share as of December 31, 2023. The 0.8% decline is driven by stable core credit performance, offset by a decrease in value in one of the Company's equity positions Internal risk rating improved with 96.5% of the portfo...

 PRESS RELEASE

Beyond Cancer Selected to Present on the Clinical Development of Ultra...

Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting Company to host an event featuring key opinion leaders (KOLs) on Friday, May 31st in Chicago to highlight the ongoing clinical development of UNO HAMILTON, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, today announced being selected to present on the clinica...

 PRESS RELEASE

Piedmont Office Realty Trust Reports First Quarter 2024 Results

Piedmont Office Realty Trust Reports First Quarter 2024 Results Atlanta, April 30, 2024 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust, Inc. ("Piedmont" or the "Company") (NYSE:PDM), an owner of Class A office properties located primarily in major U.S. Sunbelt markets, today announced its results for the quarter ended March 31, 2024 which included significant leasing activity, strong Same Store NOI growth, as well as previously announced refinancing and disposition activity. Highlights for the Three Months Ended March 31, 2024: Financial Results:  Three Months Ended(in 000s...

 PRESS RELEASE

Kearny Financial Corp. Announces Third Quarter Fiscal 2024 Results and...

Kearny Financial Corp. Announces Third Quarter Fiscal 2024 Results and Declaration of Cash Dividend FAIRFIELD, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Kearny Financial Corp. (NASDAQ GS: KRNY) (the “Company”), the holding company of Kearny Bank (the “Bank”), reported net income for the quarter ended March 31, 2024 of $7.4 million, or $0.12 per diluted share, compared to a net loss of $13.8 million, or $0.22 per diluted share, for the quarter ended December 31, 2023. The net loss for the quarter ended December 31, 2023 was impacted by various non-recurring items, as previously disclosed. ...

 PRESS RELEASE

ACNB Corporation Reports 2024 First Quarter Financial Results

ACNB Corporation Reports 2024 First Quarter Financial Results GETTYSBURG, Pa., April 25, 2024 (GLOBE NEWSWIRE) -- ACNB Corporation (NASDAQ: ACNB) (“ACNB” or the “Corporation”), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced net income of $6.8 million, or $0.80 per diluted earnings per share, for the three months ended March 31, 2024 compared to net income of $9.0 million, or $1.06 per diluted earnings per share, for the three months ended March 31, 2023. Compared to the three months ended December 31, 2023, net income and diluted earnings per share fo...

 PRESS RELEASE

Piedmont Office Realty Trust Declares Second Quarter Dividend

Piedmont Office Realty Trust Declares Second Quarter Dividend Atlanta, April 24, 2024 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust (NYSE: PDM) (“Piedmont”), a real estate investment trust (REIT), announced today that its board of directors has declared a regular quarterly cash dividend of $0.125 per share, or $0.50 per share on an annualized basis, for the second quarter of 2024. The dividend will be paid on June 14, 2024 to stockholders of record as of the close of business on May 24, 2024. About Piedmont Office Realty Trust Piedmont Office Realty Trust, Inc. (NYSE: PDM) is an ...

 PRESS RELEASE

ACNB Corporation Announces Second Quarter Cash Dividend

ACNB Corporation Announces Second Quarter Cash Dividend GETTYSBURG, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- ACNB Corporation (NASDAQ: ACNB), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced today that the Board of Directors approved and declared a regular quarterly cash dividend of $0.32 per share of ACNB Corporation common stock payable on June 14, 2024, to shareholders of record as of May 31, 2024. This per share amount reflects a 14.2% increase over the $0.28 per share paid in the second quarter of 2023, and a 6.6% increase over the $0.30 per share p...

 PRESS RELEASE

QCR Holdings, Inc. Announces Net Income of $26.7 Million for the First...

QCR Holdings, Inc. Announces Net Income of $26.7 Million for the First Quarter of 2024 First Quarter 2024 Highlights Net income of $26.7 million, or $1.58 per diluted shareCapital Markets Revenue of $16.5 millionAnnualized core deposit growth, excluding brokered deposits, of 20.3%Increase in tangible book value (non-GAAP) per share of $1.12, or 10.2% annualizedTCE/TA ratio (non-GAAP) improved by 19 basis points to 8.94% MOLINE, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- QCR Holdings, Inc. (NASDAQ: QCRH) (the “Company”) today announced quarterly net income of $26.7 million and diluted earn...

 PRESS RELEASE

NewtekOne, Inc. CEO, Barry Sloane, to Attend the B. Riley Securities 2...

NewtekOne, Inc. CEO, Barry Sloane, to Attend the B. Riley Securities 24th Institutional Investor Conference May 22-23, 2024 BOCA RATON, Fla., April 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: NEWT), announced today that NewtekOne’s CEO and President, Barry Sloane, and CFO, M. Scott Price, will attend and hold-one-on-one meetings at the B. Riley Securities 24th Institutional Investor Conference on May 22-23, 2024 at the Beverly Hilton Hotel in Beverly Hills, CA. To schedule a meeting, please contact your B. Riley representative, or Jayne Cavuoto, Director of Investor Relations at NewtekOne, at ...

 PRESS RELEASE

Chart Industries to Supply Key Liquefaction Equipment for the Cedar LN...

Chart Industries to Supply Key Liquefaction Equipment for the Cedar LNG Project ATLANTA, April 15, 2024 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a leading global solutions provider to clean energy and industrial gas markets, announced that it has been chosen to supply critical liquefaction equipment, including the natural gas liquefaction cold boxes and brazed aluminum heat exchangers, to the Cedar liquefied natural gas (LNG) project. The Cedar LNG project brings together the Haisla Nation and Pembina Pipeline Corporation (Pembina) to develop the Haisla Nation-l...

Chart Industries, Inc.: Update to credit analysis following outlook ch...

Our credit view of this issuer reflects its strong demand trends, against its ability to maintain good free cash flow key to further deleveraging.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

David Carlson ... (+8)
  • David Carlson
  • David Nierengarten
  • Dennis Pak
  • Laura Chico
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Sam Ravina
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VRTX VERTEX PHARMACEUTICALS INCORPORATED
SRPT SAREPTA THERAPEUTICS INC.
SGMO SANGAMO THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RGNX REGENXBIO INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PCRX PACIRA BIOSCIENCES INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MNKD MANNKIND CORP.
LL LUMBER LIQUIDATORS HOLDINGS INC.
KURA KURA ONCOLOGY INC.
HD HOME DEPOT INC.
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
TSC TRISTATE CAPITAL HOLDINGS INC
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
NTLA INTELLIA THERAPEUTICS INC.
PK PARK HOTELS & RESORTS INC.
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
OVID OVID THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
VRNA VERONA PHARMA ADS
SE SEA ADS
AMD ADVANCED MICRO DEVICES INC.
APLS APELLIS PHARMACEUTICALS
UBX UNITY BIOTECHNOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
IMUX IMMUNIC INC
GOSS GOSSAMER BIO
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
APRE APREA THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
RVMD REVOLUTION MEDICINES
PASG PASSAGE BIO
ACET ADICET BIO INC
ASO ACADEMY SPORTS AND OUTDOORS
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
GBIO GENERATION BIO
PRAX PRAXIS PRECISION MEDICINES
COGT COGENT BIOSCIENCES INC
VOR VOR BIOPHARMA
NUVB NUVATION BIO INC (A)
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
OMGA OMEGA THERAPEUTICS
SBTX SILVERBACK THERAPEUTICS
TNGX TANGO THERAPEUTICS
LBPH INC
IKNA LONGBOARD PHARMACEUTICALS
TCRX IKENA ONCOLOGY INC
VERA TSCAN THERAPEUTICS INC
HOWL VERA THERAPEUTICS INC
GLUE WEREWOLF THERAPEUTICS INC
AVTE MONTE ROSA THERAPEUTICS INC
CMPX AEROVATE THERAPEUTICS INC
GMTX COMPASS THERAPEUTICS
JANX GEMINI THERAPEUTICS INC
VIGL JANUX THERAPEUTICS INC
MLTX VIGIL NEUROSCIENCE INC
TYRA MOONLAKE IMMUNOTHERAPEUTICS
PEPG TYRA BIOSCIENCES INC
HR PEPGEN INC
EWTX HEALTHCARE TRUST OF AMERICA INC.
PRME EDGEWISE THERAPEUTICS INC
OCS PRIME MEDICINE INC
APGE OCULIS HOLDING AG
DNTH APOGEE THERAPEUTICS INC
DIANTHUS THERAPEUTICS INC
 PRESS RELEASE

AFC Gamma, Inc. Schedules First Quarter 2024 Earnings Conference Call ...

AFC Gamma, Inc. Schedules First Quarter 2024 Earnings Conference Call for May 9, 2024 WEST PALM BEACH, Fla., April 10, 2024 (GLOBE NEWSWIRE) -- AFC Gamma, Inc. (NASDAQ:AFCG) (“AFC Gamma”) today announced that it plans to report earnings for the quarter ended March 31, 2024 on Thursday, May 9, 2024. AFC Gamma will host a conference call at 10:00 am Eastern Time on Thursday, May 9, 2024 to discuss its quarterly financial results. All interested parties are welcome to participate. The call will be available through a live audio webcast at the Investor Relations section of AFC Gamma’s websit...

 PRESS RELEASE

Chart Industries to Announce First Quarter 2024 Results on May 3

Chart Industries to Announce First Quarter 2024 Results on May 3 ATLANTA, April 10, 2024 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a leading global solutions provider to clean energy and industrial gas markets, has scheduled a conference call for Friday, May 3, 2024 at 8:30 a.m. ET to discuss its first quarter 2024 financial results. Chart plans to issue its first quarter 2024 earnings release prior to market open on May 3rd. Participants wishing to join the live Q&A session must dial-in with the following information: PARTICIPANT INFORMATION:Toll-Free – Nor...

 PRESS RELEASE

Piedmont Office Realty Trust, Inc. to Report First Quarter 2024 Financ...

Piedmont Office Realty Trust, Inc. to Report First Quarter 2024 Financial Results Atlanta, April 09, 2024 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust (NYSE: PDM) announced today that the Company will release its first quarter financial results on Tuesday, April 30, 2024, after the close of trading on the New York Stock Exchange. A conference call is scheduled for Wednesday, May 1, 2024 at 9:00 a.m. Eastern time and will be broadcast live in listen-only mode on the company’s investor relations website at investor.piedmontreit.com. During the conference call, the Company’s management t...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch